Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials - Husain, M; Bain, S C; Holst, A G; Mark, T; Rasmussen, S; Lingvay, I (Cardiovasc Diabetol, 2020)